vs

Side-by-side financial comparison of CLOVER HEALTH INVESTMENTS, CORP. (CLOV) and Utz Brands, Inc. (UTZ). Click either name above to swap in a different company.

CLOVER HEALTH INVESTMENTS, CORP. is the larger business by last-quarter revenue ($487.7M vs $341.0M, roughly 1.4× Utz Brands, Inc.). Utz Brands, Inc. runs the higher net margin — 0.7% vs -10.1%, a 10.8% gap on every dollar of revenue. On growth, CLOVER HEALTH INVESTMENTS, CORP. posted the faster year-over-year revenue change (44.7% vs -3.1%). Utz Brands, Inc. produced more free cash flow last quarter ($16.5M vs $-69.0M). Over the past eight quarters, CLOVER HEALTH INVESTMENTS, CORP.'s revenue compounded faster (18.6% CAGR vs -1.5%).

Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.

Utz Brands, Inc., more commonly known as Utz, is an American snack food company based in Hanover, Pennsylvania. The company produces a variety of potato chips, pretzels, and other snacks, with most products sold under their family of brands. Utz is also a snack supplier to warehouse clubs and merchandisers.

CLOV vs UTZ — Head-to-Head

Bigger by revenue
CLOV
CLOV
1.4× larger
CLOV
$487.7M
$341.0M
UTZ
Growing faster (revenue YoY)
CLOV
CLOV
+47.9% gap
CLOV
44.7%
-3.1%
UTZ
Higher net margin
UTZ
UTZ
10.8% more per $
UTZ
0.7%
-10.1%
CLOV
More free cash flow
UTZ
UTZ
$85.5M more FCF
UTZ
$16.5M
$-69.0M
CLOV
Faster 2-yr revenue CAGR
CLOV
CLOV
Annualised
CLOV
18.6%
-1.5%
UTZ

Income Statement — Q4 FY2025 vs Q4 FY2024

Metric
CLOV
CLOV
UTZ
UTZ
Revenue
$487.7M
$341.0M
Net Profit
$-49.3M
$2.3M
Gross Margin
25.5%
Operating Margin
-10.1%
2.1%
Net Margin
-10.1%
0.7%
Revenue YoY
44.7%
-3.1%
Net Profit YoY
-123.2%
108.3%
EPS (diluted)
$0.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLOV
CLOV
UTZ
UTZ
Q4 25
$487.7M
Q3 25
$496.6M
Q2 25
$477.6M
Q1 25
$462.3M
Q4 24
$337.0M
$341.0M
Q3 24
$331.0M
$365.5M
Q2 24
$356.3M
$356.2M
Q1 24
$346.9M
$346.5M
Net Profit
CLOV
CLOV
UTZ
UTZ
Q4 25
$-49.3M
Q3 25
$-24.4M
Q2 25
$-10.6M
Q1 25
$-1.3M
Q4 24
$-22.1M
$2.3M
Q3 24
$-9.2M
$-2.2M
Q2 24
$7.4M
$19.8M
Q1 24
$-19.2M
$-4.0M
Gross Margin
CLOV
CLOV
UTZ
UTZ
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
25.5%
Q3 24
24.5%
26.9%
Q2 24
30.3%
26.7%
Q1 24
23.6%
25.5%
Operating Margin
CLOV
CLOV
UTZ
UTZ
Q4 25
-10.1%
Q3 25
-4.9%
Q2 25
-2.2%
Q1 25
-0.3%
Q4 24
-6.4%
2.1%
Q3 24
-2.7%
5.3%
Q2 24
2.0%
6.3%
Q1 24
-6.5%
2.8%
Net Margin
CLOV
CLOV
UTZ
UTZ
Q4 25
-10.1%
Q3 25
-4.9%
Q2 25
-2.2%
Q1 25
-0.3%
Q4 24
-6.6%
0.7%
Q3 24
-2.8%
-0.6%
Q2 24
2.1%
5.6%
Q1 24
-5.5%
-1.2%
EPS (diluted)
CLOV
CLOV
UTZ
UTZ
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
$0.04
Q3 24
$-0.03
Q2 24
$0.23
Q1 24
$-0.05

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLOV
CLOV
UTZ
UTZ
Cash + ST InvestmentsLiquidity on hand
$78.3M
$56.1M
Total DebtLower is stronger
$768.6M
Stockholders' EquityBook value
$308.7M
$696.9M
Total Assets
$541.0M
$2.7B
Debt / EquityLower = less leverage
1.10×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLOV
CLOV
UTZ
UTZ
Q4 25
$78.3M
Q3 25
Q2 25
Q1 25
Q4 24
$194.5M
$56.1M
Q3 24
$288.0M
$64.9M
Q2 24
$254.8M
$66.6M
Q1 24
$208.3M
$47.0M
Total Debt
CLOV
CLOV
UTZ
UTZ
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
$768.6M
Q3 24
$780.8M
Q2 24
$797.6M
Q1 24
$756.9M
Stockholders' Equity
CLOV
CLOV
UTZ
UTZ
Q4 25
$308.7M
Q3 25
$340.9M
Q2 25
$344.2M
Q1 25
$336.1M
Q4 24
$341.1M
$696.9M
Q3 24
$342.2M
$685.7M
Q2 24
$324.9M
$686.0M
Q1 24
$292.5M
$671.1M
Total Assets
CLOV
CLOV
UTZ
UTZ
Q4 25
$541.0M
Q3 25
$559.7M
Q2 25
$575.0M
Q1 25
$583.7M
Q4 24
$580.7M
$2.7B
Q3 24
$653.0M
$2.6B
Q2 24
$674.2M
$2.7B
Q1 24
$671.8M
$2.6B
Debt / Equity
CLOV
CLOV
UTZ
UTZ
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
1.10×
Q3 24
1.14×
Q2 24
1.16×
Q1 24
1.13×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLOV
CLOV
UTZ
UTZ
Operating Cash FlowLast quarter
$-66.9M
$54.2M
Free Cash FlowOCF − Capex
$-69.0M
$16.5M
FCF MarginFCF / Revenue
-14.1%
4.8%
Capex IntensityCapex / Revenue
0.4%
11.1%
Cash ConversionOCF / Net Profit
23.67×
TTM Free Cash FlowTrailing 4 quarters
$-69.2M
$7.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLOV
CLOV
UTZ
UTZ
Q4 25
$-66.9M
Q3 25
$12.1M
Q2 25
$5.4M
Q1 25
$-16.3M
Q4 24
$34.8M
$54.2M
Q3 24
$50.0M
$52.2M
Q2 24
$44.8M
$8.9M
Q1 24
$25.9M
$-9.1M
Free Cash Flow
CLOV
CLOV
UTZ
UTZ
Q4 25
$-69.0M
Q3 25
$11.4M
Q2 25
$4.8M
Q1 25
$-16.5M
Q4 24
$33.3M
$16.5M
Q3 24
$49.6M
$29.1M
Q2 24
$44.4M
$-15.3M
Q1 24
$25.5M
$-22.7M
FCF Margin
CLOV
CLOV
UTZ
UTZ
Q4 25
-14.1%
Q3 25
2.3%
Q2 25
1.0%
Q1 25
-3.6%
Q4 24
9.9%
4.8%
Q3 24
15.0%
8.0%
Q2 24
12.5%
-4.3%
Q1 24
7.3%
-6.5%
Capex Intensity
CLOV
CLOV
UTZ
UTZ
Q4 25
0.4%
Q3 25
0.1%
Q2 25
0.1%
Q1 25
0.0%
Q4 24
0.5%
11.1%
Q3 24
0.1%
6.3%
Q2 24
0.1%
6.8%
Q1 24
0.1%
3.9%
Cash Conversion
CLOV
CLOV
UTZ
UTZ
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
23.67×
Q3 24
Q2 24
6.04×
0.45×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons